Scientists seek new clues to tame tough colorectal cancer
NCT ID NCT03699111
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at 29 patients with a hard-to-treat form of advanced colorectal cancer. The goal was to find new ways to group these patients based on the biology of their tumors. This could help doctors choose more effective treatments in the future. The study did not test any new drugs, but focused on analyzing tumor samples.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could lead to better personalized treatment strategies for patients with this hard-to-treat form of colorectal cancer.
What could go wrong
This was a small, observational study (29 participants) focused on data analysis, not testing a new treatment. The findings are exploratory and may not directly change patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beaumont Hospital
Dublin, Ireland
-
Bon Secours Hospital, Cork
Cork, Ireland
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain
-
Institut Catala d'Oncologia
Barcelona, Spain
-
Private Practice Oncology, Heidelberg
Heidelberg, Germany
-
Private Practice Oncology, Speyer
Speyer, Germany
-
St Vincent's University Hospital
Dublin, Ireland
-
Tallaght University Hospital
Dublin, Ireland
-
University Hospital Galway
Galway, Ireland
-
University Hospital, Mannheim
Mannheim, Germany